Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/37521| Title: | Depression and psychosis in ADCY5-related dyskinesia-part of the phenotypic spectrum?. | Authors: | Newby R.;Kempster P.A.;Vijiaratnam N. | Institution: | (Vijiaratnam) Department of Neurology, Royal Free, London, United Kingdom (Newby) Department of Neurology, Leeds General Infirmary, Leeds, United Kingdom (Kempster) Department of Neuroscience, Monash Medical Centre, Australia | Issue Date: | 18-Oct-2018 | Copyright year: | 2018 | Publisher: | Churchill Livingstone | Place of publication: | United Kingdom | Publication information: | Journal of Clinical Neuroscience. 57 (pp 167-168), 2018. Date of Publication: November 2018. | Journal: | Journal of Clinical Neuroscience | Abstract: | This report details prominent neuropsychiatric features in one family with an ADCY5 gene mutation. ADCY5 mutations cause a variable motor phenotype, though most cases have some core involuntary movement features. The psychiatric aspects of the disorder have not been emphasised in previous publications. We discuss possible pathogenesis.Copyright © 2018 Elsevier Ltd | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.jocn.2018.08.049 | Link to associated publication: | Click here for full text options | PubMed URL: | 30172639 [http://www.ncbi.nlm.nih.gov/pubmed/?term=30172639] | ISSN: | 0967-5868 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/37521 | Type: | Article | Subjects: | gait disorder gene gene mutation hospital admission human hypersalivation involuntary movement lack of drug effect male mental instability motor dysfunction/si [Side Effect] muscle hypotonia/si [Side Effect] muscle spasm/dt [Drug Therapy] myoclonus/si [Side Effect] *phenotype sequence analysis suicide attempt acetazolamide/dt [Drug Therapy] *adenylate cyclase antihistaminic agent/ae [Adverse Drug Reaction] baclofen/dt [Drug Therapy] benzodiazepine/dt [Drug Therapy] beta 2 adrenergic receptor stimulating agent/ae [Adverse Drug Reaction] carbamazepine/dt [Drug Therapy] levodopa/ae [Adverse Drug Reaction] olanzapine/cb [Drug Combination] olanzapine/dt [Drug Therapy] prednisolone/dt [Drug Therapy] sertraline/cb [Drug Combination] sertraline/dt [Drug Therapy] trihexyphenidyl/dt [Drug Therapy] valproic acid/dt [Drug Therapy] venlafaxine/ae [Adverse Drug Reaction] venlafaxine/dt [Drug Therapy] ADCY5 gene priority journal *acute psychosis/di [Diagnosis] *acute psychosis/dt [Drug Therapy] adult anxiety disorder article case report chorea clinical article *depression/di [Diagnosis] developmental coordination disorder developmental delay *disease association disease exacerbation/si [Side Effect] *dyskinesia/dt [Drug Therapy] dystonia/dt [Drug Therapy] dystonia / drug therapy gait disorder gene gene mutation hospital admission human hypersalivation involuntary movement lack of drug effect male mental instability motor dysfunction / side effect muscle hypotonia / side effect muscle spasm / drug therapy myoclonus / side effect *phenotype priority journal sequence analysis suicide attempt case report anxiety disorder adult *acute psychosis / *diagnosis / *drug therapy Article chorea clinical article *depression / *diagnosis developmental coordination disorder developmental delay *disease association disease exacerbation / side effect *dyskinesia / *drug therapy |
Type of Clinical Study or Trial: | Case series or case report |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.